113 related articles for article (PubMed ID: 38335994)
1. ETV5 Silencing Produces Mesenchymal to Epithelial Transition in INS-1 (832/13) Cell Line.
Díaz-López YE; Cázares-Domínguez V; Arenas-Huertero F; Gutierrez-Aguilar R
Horm Metab Res; 2024 Mar; 56(3):235-243. PubMed ID: 38335994
[TBL] [Abstract][Full Text] [Related]
2. ETV5 overexpression contributes to tumor growth and progression of thyroid cancer through PIK3CA.
Meng D; Li Z; Ma X; Wu L; Fu L; Qin G
Life Sci; 2020 Jul; 253():117693. PubMed ID: 32325133
[TBL] [Abstract][Full Text] [Related]
3. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.
Colas E; Muinelo-Romay L; Alonso-Alconada L; Llaurado M; Monge M; Barbazan J; Gonzalez M; Schoumacher M; Pedrola N; Ertekin T; Devis L; Ruiz A; Castellvi J; Doll A; Gil-Moreno A; Vazquez-Levin M; Lapyckyj L; Lopez-Lopez R; Robine S; Friederich E; Castro M; Reventos J; Vignjevic D; Abal M
Oncogene; 2012 Nov; 31(45):4778-88. PubMed ID: 22266854
[TBL] [Abstract][Full Text] [Related]
4. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
5. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.
Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M
Carcinogenesis; 2014 Dec; 35(12):2679-86. PubMed ID: 25233929
[TBL] [Abstract][Full Text] [Related]
6. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression.
Nishino H; Takano S; Yoshitomi H; Suzuki K; Kagawa S; Shimazaki R; Shimizu H; Furukawa K; Miyazaki M; Ohtsuka M
Cancer Med; 2017 Nov; 6(11):2686-2696. PubMed ID: 28960866
[TBL] [Abstract][Full Text] [Related]
7. The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells.
Puli OR; Danysh BP; McBeath E; Sinha DK; Hoang NM; Powell RT; Danysh HE; Cabanillas ME; Cote GJ; Hofmann MC
Neoplasia; 2018 Nov; 20(11):1121-1134. PubMed ID: 30265861
[TBL] [Abstract][Full Text] [Related]
8. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
[TBL] [Abstract][Full Text] [Related]
9. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
10. Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
Wang M; Meng J; Wang H; Hu H; Hong Y
J Cell Mol Med; 2024 Feb; 28(4):e18081. PubMed ID: 38358034
[TBL] [Abstract][Full Text] [Related]
11. ETV5 transcriptionally activates TGFβ1 and promotes cancer cell invasion and migration of NSCLC.
Li D; Shen Y; Ren H; Wang L; Yang J; Wang Y
J Mol Histol; 2023 Oct; 54(5):419-426. PubMed ID: 37656259
[TBL] [Abstract][Full Text] [Related]
12. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
13. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
14. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.
Pedrola N; Devis L; Llauradó M; Campoy I; Martinez-Garcia E; Garcia M; Muinelo-Romay L; Alonso-Alconada L; Abal M; Alameda F; Mancebo G; Carreras R; Castellví J; Cabrera S; Gil-Moreno A; Matias-Guiu X; Iovanna JL; Colas E; Reventós J; Ruiz A
Clin Exp Metastasis; 2015 Jun; 32(5):467-78. PubMed ID: 25924802
[TBL] [Abstract][Full Text] [Related]
15. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation.
Zhang J; Cao H; Xie J; Fan C; Xie Y; He X; Liao M; Zhang S; Wang H
Cell Death Dis; 2018 Feb; 9(2):224. PubMed ID: 29445086
[TBL] [Abstract][Full Text] [Related]
16. Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3.
Zhu L; Qin H; Li PY; Xu SN; Pang HF; Zhao HZ; Li DM; Zhao Q
J Exp Clin Cancer Res; 2012 Mar; 31(1):29. PubMed ID: 22458379
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
[TBL] [Abstract][Full Text] [Related]
18. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
19. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
20. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
Zhu H; Qin H; Li DM; Liu J; Zhao Q
Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
